Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma

• Noriteru Doi,

  Roles Formal analysis, Investigation, Validation, Writing – original draft

  Affiliation Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan

  ⨯
• Yoshinori Ino,

  Roles Formal analysis, Investigation

  Affiliation Department of Analytical Pathology, National Cancer Center Research Institute, Tokyo, Japan

  ⨯
• Kiyohiko Angata,

  Roles Investigation, Writing – review & editing

  Affiliation Department of Life Science and Biotechnology, The Glycoscience and Glycotechnology Research Group, Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan

  ⨯
• Kazuaki Shimada,

  Roles Resources

  Affiliation Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan

  ⨯
• Hisashi Narimatsu,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Life Science and Biotechnology, The Glycoscience and Glycotechnology Research Group, Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan

  ⨯
• Nobuyoshi Hiraoka

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: nhiraoka@ncc.go.jp

  Affiliations Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan, Department of Analytical Pathology, National Cancer Center Research Institute, Tokyo, Japan, Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan

  https://orcid.org/0000-0003-4215-4385

  ⨯